[Form 4] LOEWS CORP Insider Trading Activity

Rhea-AI Filing Summary

Jennifer VanBelle, a director of Loews Corporation (ticker: L), was granted 156 shares of Common Stock as a quarterly director compensation award under the Loews Corporation 2025 Incentive Compensation Plan. The transaction date is 09/30/2025 and the shares were reported at a $0 price, reflecting a grant rather than a purchase. Following the grant, Ms. VanBelle beneficially owns 156 shares in a direct capacity. The Form 4 was signed on behalf of Ms. VanBelle by Thomas H. Watson under power of attorney on 09/30/2025. No derivative transactions, dispositions, or other changes in ownership are reported in this filing.

Insights

Financial Analyst

TL;DR: Routine director equity grant of 156 shares on 09/30/2025 recorded as compensation, minimal direct ownership disclosed.

The filing documents a standard quarterly equity grant to a board director under the company's 2025 Incentive Compensation Plan. The grant is reported at $0, indicating it is compensation rather than an open-market purchase. The post-transaction direct beneficial ownership is 156 shares, which is a small absolute holding and does not by itself signal material change to capital structure or control. The disclosure is timely, properly executed by power of attorney, and contains no derivative or disposition activity.

Corporate Governance Expert

TL;DR: Routine director compensation disclosure; compliance with Section 16 reporting appears satisfied.

The Form 4 reports a director compensation grant and identifies the relationship (Director). The explanation states the grant is part of the 2025 Incentive Compensation Plan, and the signature was completed by an authorized agent. As presented, the filing fulfills disclosure requirements for insider changes in beneficial ownership without indicating governance concerns or unusual arrangements. There is no evidence in the filing of accelerated vesting, loans, or related-party transfers.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

VanBelle Jennifer

(Last) (First) (Middle)

C/O LOEWS CORPORATION

9 WEST 57TH STREET

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LOEWS CORP [ L ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A		156	A(1)	$0	156	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents quarterly grant of common stock in respect of director compensation under the Loews Corporation 2025 Incentive Compensation Plan.

Remarks:

	/s/ Thomas H. Watson by power of attorney for Jennifer VanBelle	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jennifer VanBelle report on the Form 4 for Loews Corporation (L)?

The Form 4 reports a grant of 156 common shares to Jennifer VanBelle as director compensation under the 2025 Incentive Compensation Plan, dated 09/30/2025.

How many shares does Jennifer VanBelle beneficially own after the reported transaction?

Following the reported grant, Ms. VanBelle beneficially owns 156 shares in a direct ownership form.

Was the reported transaction a purchase or a compensation grant?

The transaction is reported with a price of $0, indicating it was a compensation grant, not an open-market purchase.

When was the Form 4 signed and by whom?

The Form 4 was signed on 09/30/2025 by Thomas H. Watson under power of attorney for Jennifer VanBelle.

Does the Form 4 show any derivative securities or dispositions for Ms. VanBelle?

No. Table II (derivative securities) and dispositions are not reported; only a non-derivative grant of common stock is disclosed.